Journal Club - Black Garlic demonstrates hypocholesterolemic properties when aged

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-04-21 03:30 GMT   |   Update On 2022-04-21 08:43 GMT

In People who have moderately raised levels of cholesterol, Aged Black Garlic has demonstrated potent blood pressure balancing properties.The company working on it grows and cultivates it locally. It uses a green technology process that generates very low waste and significantly reduces the environmental impact. The randomized, double-blind, sustained, crossover-controlled intervention...

Login or Register to read the full article

In People who have moderately raised levels of cholesterol, Aged Black Garlic has demonstrated potent blood pressure balancing properties.

The company working on it grows and cultivates it locally. It uses a green technology process that generates very low waste and significantly reduces the environmental impact. The randomized, double-blind, sustained, crossover-controlled intervention was published in the science journal Nutrients on January 18, 2022. It was conducted at the Sant Joan de ReusUniversity Hospital in Barcelona. The study was led by Dr. Rosa Valls who is the author of more than 150 scientific papers and director of dozens of doctoral theses. The study included 67 adult volunteers who had high cholesterol levels with relatively high blood LDL levels.

Each participant consumed 250mg ABG+ or a placebo over six weeks, with a three-week washout period before crossover. Subjects also were assigned a set diet that excluded lipo-lowering and anti-hypertensive foods.

Results at six weeks demonstrated that ABG+ extract significantly reduced diastolic blood pressure by 5.85mm Hg on average compared to the placebo. The favorable reaction was particularly evident in men. High blood pressure affects nearly a third of adults worldwide and is the leading preventable risk factor for cardiovascular problems and all-cause mortality. The risks associated with common cardiovascular problems and stroke double with every 10mm Hg diastolic increase among people aged 40 to 89.

This is the first clinical study conducted on ABG+, spurred by the company's encouraging results of two previous animal studies. Those trials demonstrated the ingredient's cardioprotective role, as well as its ability to favorably balance blood lipids and enhance vascular function. 

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News